Lilly’s Zepbound plus Taltz sustains stronger psoriasis and psoriatic arthritis outcomes at one year
Eli Lilly and Company says one-year Phase 3b data from TOGETHER-PsO and TOGETHER-PsA show sustained or deeper improvements when Zepbound and Taltz are used together in patients living with psoriatic disease and obesity.